Heyuan Biotech (688238.SH) disclosed its 2023 annual report, and the company achieved revenue of 2 in 2023...
Zhitong Finance App News, Heyuan Biotech (688238.SH) disclosed the 2023 annual report. The company achieved revenue of 205 million yuan in 2023, a year-on-year decrease of 29.69%; net profit loss to mother of 128 million yuan, which changed from profit to loss over the previous year; after deducting loss of 134 million yuan in non-net profit, which changed from profit to loss over the previous year; basic earnings per share -0.199 yuan.